Skip to content

Clinical trials

Lung Diseases trials in Czechia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Diseases Country / region: Czechia Clear all

29 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20091
20101
20111
20131
20143
20162
20181
20194
20223
20231
20244
20254
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13
Recruiting9
Active, not recruiting4
Terminated2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca8
Pfizer3
Eli Lilly and Company2
Novartis Pharmaceuticals2
United Therapeutics2
Upstream Bio Inc.2
Bayer1
Carebot s.r.o.1
Daiichi Sankyo1
Nuvalent Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Diseases29
Respiratory Tract Diseases17
Asthma9
Bronchial Diseases8
Lung Diseases, Obstructive6
Lung Neoplasms6
Carcinoma, Non-Small-Cell Lung5
Pulmonary Disease, Chronic Obstructive5
Bronchial Neoplasms3
COVID-193

Trials

Showing 1 to 25 of 29. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.